Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2025)

Bicycle Therapeutics' Tax Provisions history spans 8 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 288.18% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $976000.0, up 120.32%, while the annual FY2025 figure was $1.0 million, 120.88% up from the prior year.
  • Tax Provisions reached $2.1 million in Q4 2025 per BCYC's latest filing, up from $205000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $4.6 million in Q4 2022 to a low of -$3.4 million in Q3 2024.
  • Average Tax Provisions over 5 years is -$188950.0, with a median of -$400000.0 recorded in 2022.
  • Peak YoY movement for Tax Provisions: tumbled 1287.27% in 2021, then skyrocketed 1236.0% in 2023.
  • A 5-year view of Tax Provisions shows it stood at -$763000.0 in 2021, then surged by 697.12% to $4.6 million in 2022, then tumbled by 164.73% to -$2.9 million in 2023, then soared by 62.12% to -$1.1 million in 2024, then skyrocketed by 288.18% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Tax Provisions are $2.1 million (Q4 2025), $205000.0 (Q3 2025), and -$231000.0 (Q2 2025).